Nifty
:
23750.20
Sensex
:
78472.48
22.55 (0.10%)
-0.39 (0.00%)
Nifty
Sensex
:
:
23750.20
78472.48
22.55 (0.10%)
-0.39 (0.00%)

Medplus Health Services Ltd.

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 543427 | NSE: MEDPLUS

NSE BSE
830.50
26-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  837.80
  •  850.00
  •  825.05
  •  836.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  182678
  •  1526.75
  •  875.65
  •  598.60

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 9,938.78
  • 100.00
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 9,671.18
  • N/A
  • 6.11

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 40.39%
  • 3.11%
  • 11.84%
  • FII
  • DII
  • Others
  • 14.72%
  • 21.11%
  • 8.83%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 14.40
  • 14.17

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 22.67
  • 5.15

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 105.42
  • -11.92

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 153.85

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 5.90

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 29.28

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
5.48
11.12
16.36
22.88
P/E Ratio
135.89
66.98
45.52
32.54
Revenue
5625
6366
7421
8631
EBITDA
354
490
607
750
Net Income
65
135
201
281
ROA
2.3
4.3
5.8
7.4
P/Bk Ratio
5.64
5.2
4.68
4.12
ROE
4.27
7.77
10.87
13.52
FCFF
72.88
308.84
262.52
310.04
FCFF Yield
0.74
3.14
2.67
3.15

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
1,576.17
1,408.59
11.90%
1,488.83
1,284.30
15.93%
1,490.50
1,252.98
18.96%
1,441.47
1,190.31
21.10%
Expenses
1,451.73
1,323.50
9.69%
1,395.06
1,212.95
15.01%
1,384.63
1,171.35
18.21%
1,349.69
1,118.59
20.66%
EBITDA
124.44
85.09
46.25%
93.76
71.34
31.43%
105.87
81.63
29.69%
91.78
71.72
27.97%
EBIDTM
7.89%
6.04%
6.30%
5.56%
7.10%
6.51%
6.37%
6.03%
Other Income
11.60
10.37
11.86%
8.71
9.39
-7.24%
10.46
13.69
-23.59%
9.79
11.36
-13.82%
Interest
25.12
23.54
6.71%
24.66
23.27
5.97%
25.13
22.27
12.84%
24.50
21.08
16.22%
Depreciation
63.14
55.47
13.83%
60.03
52.41
14.54%
59.21
55.80
6.11%
57.11
45.79
24.72%
PBT
47.78
16.44
190.63%
17.79
5.05
252.28%
31.99
17.25
85.45%
19.96
16.21
23.13%
Tax
9.08
1.90
377.89%
3.44
1.29
166.67%
-1.58
-9.30
-
6.26
2.83
121.20%
PAT
38.70
14.54
166.16%
14.34
3.76
281.38%
33.56
26.56
26.36%
13.71
13.38
2.47%
PATM
2.46%
1.03%
0.96%
0.29%
2.25%
2.12%
0.95%
1.12%
EPS
3.24
1.22
165.57%
1.20
0.32
275.00%
2.79
2.23
25.11%
1.15
1.12
2.68%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Net Sales
5,996.97
5,624.85
4,557.58
3,779.28
3,069.27
2,870.60
Net Sales Growth
16.76%
23.42%
20.59%
23.13%
6.92%
 
Cost Of Goods Sold
4,638.08
4,391.63
3,557.69
2,982.37
2,425.24
2,336.54
Gross Profit
1,358.89
1,233.23
999.89
796.90
644.03
534.07
GP Margin
22.66%
21.92%
21.94%
21.09%
20.98%
18.60%
Total Expenditure
5,581.11
5,253.56
4,276.21
3,490.40
2,840.05
2,736.93
Power & Fuel Cost
-
45.50
31.71
17.78
13.29
13.70
% Of Sales
-
0.81%
0.70%
0.47%
0.43%
0.48%
Employee Cost
-
625.52
545.13
393.92
338.65
272.40
% Of Sales
-
11.12%
11.96%
10.42%
11.03%
9.49%
Manufacturing Exp.
-
9.11
6.19
4.57
6.18
8.28
% Of Sales
-
0.16%
0.14%
0.12%
0.20%
0.29%
General & Admin Exp.
-
76.56
62.06
39.66
24.88
21.00
% Of Sales
-
1.36%
1.36%
1.05%
0.81%
0.73%
Selling & Distn. Exp.
-
98.28
67.76
47.35
29.27
47.58
% Of Sales
-
1.75%
1.49%
1.25%
0.95%
1.66%
Miscellaneous Exp.
-
6.96
5.67
4.75
2.54
37.43
% Of Sales
-
0.12%
0.12%
0.13%
0.08%
1.30%
EBITDA
415.85
371.29
281.37
288.88
229.22
133.67
EBITDA Margin
6.93%
6.60%
6.17%
7.64%
7.47%
4.66%
Other Income
40.56
40.01
46.08
31.36
21.55
17.28
Interest
99.41
113.65
98.72
82.94
67.40
46.80
Depreciation
239.49
224.21
181.56
119.36
88.27
74.81
PBT
117.52
73.44
47.16
117.94
95.10
29.36
Tax
17.20
7.87
-2.94
23.23
31.99
27.57
Tax Rate
14.64%
10.72%
-6.23%
19.70%
33.64%
93.90%
PAT
100.31
65.48
49.76
95.81
63.86
1.79
PAT before Minority Interest
100.23
65.58
50.10
94.72
63.11
1.79
Minority Interest
-0.08
-0.10
-0.34
1.09
0.75
0.00
PAT Margin
1.67%
1.16%
1.09%
2.54%
2.08%
0.06%
PAT Growth
72.24%
31.59%
-48.06%
50.03%
3,467.60%
 
EPS
8.39
5.48
4.16
8.02
5.34
0.15

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Shareholder's Funds
1,577.93
1,491.18
1,417.77
730.55
527.80
Share Capital
23.91
23.86
23.86
0.45
0.19
Total Reserves
1,523.66
1,436.88
1,382.52
681.45
291.47
Non-Current Liabilities
839.74
797.40
647.39
381.01
298.35
Secured Loans
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
55.71
61.33
94.94
18.35
17.74
Current Liabilities
525.93
476.58
559.01
444.84
481.09
Trade Payables
253.03
260.14
246.23
148.09
234.15
Other Current Liabilities
241.81
189.35
148.29
111.39
122.35
Short Term Borrowings
0.00
0.00
142.68
135.24
105.05
Short Term Provisions
31.09
27.09
21.80
50.12
19.54
Total Liabilities
2,943.03
2,764.48
2,623.65
1,556.95
1,308.54
Net Block
1,241.83
1,137.96
798.73
517.30
419.46
Gross Block
1,861.94
1,615.62
1,114.11
739.16
689.67
Accumulated Depreciation
620.11
477.66
315.38
221.86
270.21
Non Current Assets
1,375.48
1,283.77
991.95
603.97
492.76
Capital Work in Progress
11.08
25.47
20.45
5.54
4.94
Non Current Investment
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
116.72
120.19
172.75
81.08
68.33
Other Non Current Assets
5.85
0.15
0.02
0.05
0.04
Current Assets
1,567.55
1,480.72
1,631.71
952.98
815.78
Current Investments
0.00
0.03
0.03
0.03
0.25
Inventories
1,340.23
1,144.09
914.98
749.96
643.55
Sundry Debtors
17.50
8.65
6.04
5.37
6.40
Cash & Bank
141.68
283.83
34.41
118.59
140.69
Other Current Assets
68.13
9.91
31.74
7.69
24.87
Short Term Loans & Adv.
53.84
34.20
644.51
71.34
18.16
Net Current Assets
1,041.62
1,004.14
1,072.70
508.14
334.69
Total Assets
2,943.03
2,764.49
2,623.66
1,556.95
1,308.54

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Cash From Operating Activity
143.74
90.41
169.89
2.89
-6.59
PBT
73.44
47.16
117.94
95.10
29.36
Adjustment
330.62
272.76
187.88
182.28
155.41
Changes in Working Capital
-231.10
-215.58
-102.37
-245.77
-176.50
Cash after chg. in Working capital
172.96
104.34
203.45
31.61
8.27
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
-29.22
-13.94
-33.56
-28.71
-14.86
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-82.80
429.44
-703.13
-34.55
-27.55
Net Fixed Assets
-17.99
-111.19
-80.06
-17.76
Net Investments
-12.56
-498.71
-9.95
-27.41
Others
-52.25
1,039.34
-613.12
10.62
Cash from Financing Activity
-198.10
-170.25
440.43
-5.63
89.83
Net Cash Inflow / Outflow
-137.17
349.60
-92.81
-37.28
55.69
Opening Cash & Equivalents
228.38
-121.23
-28.42
8.87
-46.82
Closing Cash & Equivalent
91.21
228.38
-121.23
-28.42
8.87

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Book Value (Rs.)
129.47
122.44
117.89
3044.19
15034.43
ROA
2.30%
1.86%
4.51%
4.40%
0.18%
ROE
4.36%
3.50%
9.07%
12.96%
0.59%
ROCE
12.19%
9.56%
16.56%
21.69%
14.34%
Fixed Asset Turnover
3.28
3.39
4.13
4.38
6.75
Receivable days
0.84
0.58
0.54
0.69
0.96
Inventory Days
79.52
81.27
79.28
81.18
65.97
Payable days
21.33
25.98
24.13
28.76
24.12
Cash Conversion Cycle
59.03
55.87
55.69
53.10
42.81
Total Debt/Equity
0.00
0.00
0.10
0.20
0.36
Interest Cover
1.65
1.48
2.42
2.41
1.63

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011

News Update:


  • Premji Invest, SBI Mutual Fund divest 6.6% stake in MedPlus Health Services
    19th Nov 2024, 11:30 AM

    The shares were sold at an average price of Rs 700 apiece, taking the transaction value to Rs 552.55 crore

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.